Human Proteome Mapped

Compiling mass spectrometry profiles of human tissues and cell lines, two separate groups publish near-complete drafts of the human proteome.

Written byAnna Azvolinsky
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

H. HAHNE, TECHNISCHE UNIVERSITÄT MÜNCHENTwo international teams have independently produced the first drafts of the human proteome. These curated catalogs of the proteins expressed in most non-diseased human tissues and organs can be used as a baseline to better understand changes that occur in disease states. Their findings were published today (May 29) in Nature.

Both teams uncovered new complexities of the human genome, identifying novel proteins from regions of the genome previously thought to be non-coding.

“While other large proteomic data sets have been collected that cataloged up to 10,000 proteins, the real breakthrough with these two projects is the comprehensive coverage of more than 80 percent of the expected human proteome which has not been achieved previously,” said Hanno Steen, director of proteomics at Boston Children's Hospital, who was not involved in the work. “These efforts clearly show that to get to this deep level of proteome coverage, many different tissue types must be probed.”

Analyzing 30 different tissue types, Akhilesh Pandey, a proteomics researcher at Johns Hopkins University in Baltimore, Maryland, and his colleagues at the Institute ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • head shot of blond woman wearing glasses

    Anna Azvolinsky received a PhD in molecular biology in November 2008 from Princeton University. Her graduate research focused on a genome-wide analyses of genomic integrity and DNA replication. She did a one-year post-doctoral fellowship at Memorial Sloan Kettering Cancer Center in New York City and then left academia to pursue science writing. She has been a freelance science writer since 2012, based in New York City.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies